Iridex (IRIX) EBITDA Margin Growth (1y) (2011 - 2026)
Iridex (IRIX) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 146.00 |
| 10 | Iridex | 13.32 Mn | 8.64 Mn | 4.30 Mn | -126.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -102.00 |
| Jan 3, 2026 | 385.00 |
| Sep 27, 2025 | 484.00 |
| Jun 28, 2025 | 1,396.00 |
| Mar 29, 2025 | 2,628.00 |
| Dec 28, 2024 | 2,078.00 |
| Sep 28, 2024 | -301.00 |
| Jun 29, 2024 | 163.00 |
| Mar 30, 2024 | -1,090.00 |
| Dec 30, 2023 | -1,545.00 |
| Sep 30, 2023 | -155.00 |
| Jul 1, 2023 | -681.00 |
| Apr 1, 2023 | -9.00 |
| Dec 31, 2022 | -509.00 |
| Oct 1, 2022 | 468.00 |
| Jul 2, 2022 | -723.00 |
| Apr 2, 2022 | -161.00 |
| Oct 2, 2021 | 471.00 |
| Jul 3, 2021 | 3,629.00 |
| Apr 3, 2021 | 293.00 |